Thinly traded nano cap ENDRA Life Sciences (NDRA +52.2%) is trying to break out of its downtrend on a healthy 45x surge in volume. Shares had lost almost 70% of their value this year before today's action.
At the end of March, the company had ~$3.2M in cash while operations consumed ~$2.5M in Q1 so investors should expect a capital raise in the near future.
Previously: ENDRA Life Sciences continues post-IPO stumble, down 14% (May 18)
Update: Approaching the close on June 6, shares are exchanging hands at $1.70, down 51% from the intraday high of $3.50 the day before.
Subscribe for full text news in your inbox